Skip to content

LegitScript Identifies Merchants Marketing Supplements as Drugs Following FDAs Warning Against Fraudulent Flu Products

Pills on a computer keyboard

The US Food and Drug Administration (FDA) recently released a consumer update warning against fraudulent flu products on the market in 2022-2023 flu season. LegitScript has identified websites that appear to be marketing homeopathic products and dietary supplements claiming to treat or cure seasonal flu. Keep reading to understand the FDA’s warning and some problematic claims made by these products.

Some Fraudulent Flu Products Use Problematic Marketing — Prompting FDA Warning Letters

According to the FDA, if “a product is intended to treat, diagnose, cure, or prevent diseases, it is a drug, even if it is labeled as a dietary supplement.” The FDA actively pursues companies misbranding supplements and over-the-counter products.

Merchants making false drug claims may face a warning letter. In an October 2022 letter issued to Rosebud's Ranch and Garden, LLC, the administration pointed to impermissible claims on the merchant’s website and social media accounts about their tea products’ ability to treat the flu and other diseases.

Some of these claims, according to the warning letter, included:

  • “Eases the discomfort of a cold or flu”
  • “Eases Muscular Pain”
  • “Cancer Preventer”
  • “Blood Sugar Balancer”
  • “lowering bad cholesterol”

The letter stated that the “claims on your websites establish the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease.”

In the course of our monitoring work, LegitScript has identified websites marketing dietary supplements, vitamins, and herbs with claims they increase immunity and reduce the symptoms of upper respiratory illnesses like the flu.

LegitScript uncovered fraudulent flu products.

A website known to LegitScript markets an “Anti-Viral Immunity Booster” dietary supplement with language that claims it treats respiratory infections, viral fever, seasonal flu, COVID-19, and more.

Products Marketed Problematically May Include These Types of Claims

The FDA has warned consumers to look out for potentially fraudulent flu and antiviral products being sold without a prescription. Such products may claim to:

  • Reduce the severity and length of flu or other viral infections
  • Boost your immunity naturally without a flu vaccine
  • Act as a safe and effective alternative to the flu vaccine
  • Prevent catching the flu or viral infections
  • Be an effective treatment for flu or viral infections
  • Provide faster recovery from the flu or viral infections
  • Support your body’s natural immune defenses to fight off flu or other viruses
  • Want to Learn More About How To Correctly Advertise Supplements Online?

Are you a supplement seller, or do you process payments for supplement merchants? Our comprehensive guide The Dos and Don’ts of Internet Supplement Ads sheds light on common compliance issues supplement merchants face every day. Topics covered include everything from sponsored content and endorsements to user experience and popups. Click the image or button below to download your free guide today.

cover of supplement marketing gudie showing a pile of viatmins and supplements.

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

Industry Experts Talked About These Three Key Issues at the Marketplace Risk Global Summit

The Marketplace Risk Global Summit, which took place this month in London, provided a space for the experts, founders, and industry leaders of online platforms to share their experiences, strategies, and forward-thinking solutions to the most pressing challenges in risk management, trust & safet...

FTC Payments Enforcement Trends: Key Takeaways for Payment Service Providers

The Federal Trade Commission continues to scrutinize the payments ecosystem, viewing these companies as critical gatekeepers in the fight against consumer fraud. LegitScript's recent webinar, FTC Payments Enforcement Trends: What Merchant Acquirers and Payment Service Providers Need to Know, examine...

Navigating AI’s Gray Areas: Why Human Oversight Still Matters

Artificial intelligence is changing the way organizations identify risk, monitor compliance, and make policy decisions. But as the technology evolves, so does the challenge of knowing where its limits lie. During a recent panel at Marketplace Risk NYC, Tom Cook, Chief Product and Technology Officer,...

LegitScript Marketplace Risk NYC Panel Recap: AI Blind Spots: The Gray Areas of Risk, Policy & Regulation

AI agents are transforming workflow automation, bringing speed, scale, and intelligence to complex processes. Think of them as well-read interns: capable but inexperienced, requiring context and human judgment. As their role expands, how do we ensure automation enhances, rather than replaces, though...